Marex Group Limited Reports Record Q3 2026 Financial Results
Marex Group Limited announced record financial performance for the third quarter of 2026, with revenue increasing 53% year-on-year to $743.2 million.
Stocks · News reference
Barclays Maintains Overweight on Marex Group, Raises Price Target to $95
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Marex Appoints Kory Sorenson to Group Board
Marex Group plc has announced the appointment of Kory Sorenson to its Group Board of Directors.
Premialab and Marex Launch Institutional Quantitative Investment Strategies Indices on Digital Assets
Marex has partnered with Premialab to launch the market's first institutional quantitative investment strategies (QIS) indices focused on digital assets.
Schall Brown & Schwartz LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of Marex Group plc ordinary shares - MRX
A proposed class action settlement of $950,000 has been reached on behalf of purchasers of Marex Group plc ordinary shares who bought between November 7, 2024 and August 5, 2025. The settlement requires court approval at a hearing scheduled for February 2, 2027. Class members must submit claim forms by January 11, 2027 to be eligible for compensation.
William Blair Initiates Coverage On Marex Group with Outperform Rating
William Blair analyst Jeff Schmitt initiates coverage on Marex Group (NASDAQ:MRX) with a Outperform rating.
Barclays Maintains Overweight on Marex Group, Raises Price Target to $92
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $86 to $92.